SmokingModifiableRisk Factor foratherosclerosisPCSK9InhibitorsThe mosteffective drugat loweringLDL and is aninjectableStatinSideeffectsADRs of thisdrug includeelevated liverenzymes,hepatotoxicity,and myalgiaHMG-CoAReductaseInhibitorsFirst linetreatment forhyperlipidemiaPrimarydyslipidemiaThis disorderoccursindependentof other healthproblemsHigh-IntensityAtorvastatin40mg isconsideredthis type ofintensitySmallIntestineChylomicronsare madehereOmega-3 FattyAcidsAlthough thisdrug can lowerTGs, it does notreduce CVmorbidity andmortalityModerate-IntensityPitavastatinisconsideredthis type ofintensities>40mg/dLIdeal levelof HDL formen>200mg/dLThis level ofTC on afasting panel isdiagnostic ofhyperlipidemiaFamilialHypercholesterolemia This disordercauses genemutations forLDLreceptorsLiverSynthesizesVLDL andHDL fromremants ofcholesterolLDLCholesterolThislipoprotein ismade up of50%cholesterol>500mg/dLThis level ofTGs puts apatient at riskfor developingpancreatitisFibratesGemfibrozilbelongs tothis class ofmedications<150mg/dLOptimallevel ofTGsFattystreakThe initiallesion of anatheroscleroticplaqueXanthomasPhysicalexam findingc/whyperlipidemiaSecondarydyslipidemiaThis disorderoccurs dueto otherhealthproblemsAtherosclerosisHardening ofthe arteriesby way ofcholesterolplaquesBile AcidSequestrantsThis class ofdrugs caninterfere withthe absorptionof Vit D<70mg/dLTargetLDL goalfor DM ptsNiacinThis drug ismosteffective inincreasingHDLHDLCholesterol Thislipoprotein isprotectiveagainst heartdiseaseLifestyleChangesThe bestprevention forthedevelopment ofatherosclerosisTriglyceridesThismoleculemakes up55-65% ofVLDLChylomicronsThislipoproteinprimarilytransportsTGsSmokingModifiableRisk Factor foratherosclerosisPCSK9InhibitorsThe mosteffective drugat loweringLDL and is aninjectableStatinSideeffectsADRs of thisdrug includeelevated liverenzymes,hepatotoxicity,and myalgiaHMG-CoAReductaseInhibitorsFirst linetreatment forhyperlipidemiaPrimarydyslipidemiaThis disorderoccursindependentof other healthproblemsHigh-IntensityAtorvastatin40mg isconsideredthis type ofintensitySmallIntestineChylomicronsare madehereOmega-3 FattyAcidsAlthough thisdrug can lowerTGs, it does notreduce CVmorbidity andmortalityModerate-IntensityPitavastatinisconsideredthis type ofintensities>40mg/dLIdeal levelof HDL formen>200mg/dLThis level ofTC on afasting panel isdiagnostic ofhyperlipidemiaFamilialHypercholesterolemia This disordercauses genemutations forLDLreceptorsLiverSynthesizesVLDL andHDL fromremants ofcholesterolLDLCholesterolThislipoprotein ismade up of50%cholesterol>500mg/dLThis level ofTGs puts apatient at riskfor developingpancreatitisFibratesGemfibrozilbelongs tothis class ofmedications<150mg/dLOptimallevel ofTGsFattystreakThe initiallesion of anatheroscleroticplaqueXanthomasPhysicalexam findingc/whyperlipidemiaSecondarydyslipidemiaThis disorderoccurs dueto otherhealthproblemsAtherosclerosisHardening ofthe arteriesby way ofcholesterolplaquesBile AcidSequestrantsThis class ofdrugs caninterfere withthe absorptionof Vit D<70mg/dLTargetLDL goalfor DM ptsNiacinThis drug ismosteffective inincreasingHDLHDLCholesterol Thislipoprotein isprotectiveagainst heartdiseaseLifestyleChangesThe bestprevention forthedevelopment ofatherosclerosisTriglyceridesThismoleculemakes up55-65% ofVLDLChylomicronsThislipoproteinprimarilytransportsTGs

PA518 Lipid Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
  1. Modifiable Risk Factor for atherosclerosis
    Smoking
  2. The most effective drug at lowering LDL and is an injectable
    PCSK9 Inhibitors
  3. ADRs of this drug include elevated liver enzymes, hepatotoxicity, and myalgia
    Statin Side effects
  4. First line treatment for hyperlipidemia
    HMG-CoA Reductase Inhibitors
  5. This disorder occurs independent of other health problems
    Primary dyslipidemia
  6. Atorvastatin 40mg is considered this type of intensity
    High-Intensity
  7. Chylomicrons are made here
    Small Intestine
  8. Although this drug can lower TGs, it does not reduce CV morbidity and mortality
    Omega-3 Fatty Acids
  9. Pitavastatin is considered this type of intensities
    Moderate-Intensity
  10. Ideal level of HDL for men
    >40mg/dL
  11. This level of TC on a fasting panel is diagnostic of hyperlipidemia
    >200mg/dL
  12. This disorder causes gene mutations for LDL receptors
    Familial Hypercholesterolemia
  13. Synthesizes VLDL and HDL from remants of cholesterol
    Liver
  14. This lipoprotein is made up of 50% cholesterol
    LDL Cholesterol
  15. This level of TGs puts a patient at risk for developing pancreatitis
    >500mg/dL
  16. Gemfibrozil belongs to this class of medications
    Fibrates
  17. Optimal level of TGs
    <150mg/dL
  18. The initial lesion of an atherosclerotic plaque
    Fatty streak
  19. Physical exam finding c/w hyperlipidemia
    Xanthomas
  20. This disorder occurs due to other health problems
    Secondary dyslipidemia
  21. Hardening of the arteries by way of cholesterol plaques
    Atherosclerosis
  22. This class of drugs can interfere with the absorption of Vit D
    Bile Acid Sequestrants
  23. Target LDL goal for DM pts
    <70mg/dL
  24. This drug is most effective in increasing HDL
    Niacin
  25. This lipoprotein is protective against heart disease
    HDL Cholesterol
  26. The best prevention for the development of atherosclerosis
    Lifestyle Changes
  27. This molecule makes up 55-65% of VLDL
    Triglycerides
  28. This lipoprotein primarily transports TGs
    Chylomicrons